Ritivel
The company offers an AI-native regulatory platform designed for the life sciences sector, automating critical regulatory workflows such as drafting Clinical Study Reports and CTD modules. It utilizes a domain-specific language model that understands medical terminology and operates on local infrastructure to ensure data security and compliance.
- Industry: !NA / Not Sure (AI-suggested classification)
- Location: San Francisco, California, United States
- Founded: 2025-01-01
- Total funding: 500000
- Website: https://ritivel.com
Product & Features
- Searches and interprets the latest FDA, EMA, and ICH regulations for drugs and medical devices.
- Provides instant answers from official regulatory sources and guidelines.
- Offers product-specific guidance for bioequivalence and formulation recommendations.
- Delivers up-to-date regulatory information with plain-language interpretations.
- Enables searching across all internal documents, studies, and regulatory submissions.
- Generates cross-study insights from your company's proprietary data.
- Supports secure, on-premise deployment for internal data searches.
Frequently Asked Questions
What is Ritivel?
The company offers an AI-native regulatory platform designed for the life sciences sector, automating critical regulatory workflows such as drafting Clinical Study Reports and CTD modules. It utilizes a domain-specific language model that understands medical terminology and operates on local…
What does Ritivel do?
Searches and interprets the latest FDA, EMA, and ICH regulations for drugs and medical devices. Provides instant answers from official regulatory sources and guidelines. Offers product-specific guidance for bioequivalence and formulation recommendations.
What category does Ritivel fall under?
Ritivel is a legal technology company in the !NA / Not Sure (AI-suggested classification) category.
Where is Ritivel based?
Ritivel is based in San Francisco, California, United States.
When was Ritivel founded?
Ritivel was founded in 2025.